ValiRx technology has potential for "wide range" of treatments
04:04 EDT 2 Aug 2012 | Proactive Investors
ValiRx (LON:VAL) said today it has made progress in all areas of the business after completing a two year international grant programme for its gene-silencing technology. ValiRx has been the leader of the Eurostar Programme, an international c..
Original Article: ValiRx technology has potential for "wide range" of treatments
More From BioPortfolio on "ValiRx technology has potential for "wide range" of treatments"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
